A detailed history of Alpha Star Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alpha Star Capital Management, LLC holds 9,379 shares of BMY stock, worth $543,982. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,379
Holding current value
$543,982
% of portfolio
0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $371,971 - $485,363
9,379 New
9,379 $485,000
Q4 2023

Feb 07, 2024

BUY
$48.48 - $57.85 $413,243 - $493,113
8,524 New
8,524 $437,000
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $18,968 - $22,461
-277 Reduced 4.17%
6,372 $458,000
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $73 - $43,414
565 Added 9.29%
6,649 $473,000
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $156,496 - $172,356
-2,155 Reduced 26.16%
6,084 $468,000
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $113,860 - $136,529
1,852 Added 29.0%
8,239 $602,000
Q4 2021

Feb 04, 2022

SELL
$53.63 - $62.52 $134,557 - $156,862
-2,509 Reduced 28.2%
6,387 $415,000
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $526,376 - $616,581
8,896 New
8,896 $514,000
Q1 2020

May 05, 2020

SELL
$46.4 - $67.43 $488,452 - $709,835
-10,527 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $89,906 - $117,275
1,827 Added 21.0%
10,527 $676,000
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $42,727 - $50,659
999 Added 12.97%
8,700 $441,000
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $343,618 - $379,967
7,701 New
7,701 $349,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alpha Star Capital Management, LLC Portfolio

Follow Alpha Star Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Star Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Star Capital Management, LLC with notifications on news.